Cargando…
Selectivity to amyloid-β precursor protein cleavage provides hope against Alzheimer's
Toward development of a safe and effective treatment for Alzheimer's disease, Elan Pharmaceuticals reported a novel γ-secretase inhibitor that specifically targets the cleavage of amyloid-β precursor protein, opening the way to design of substrate-specific γ-secretase inhibitors that would redu...
Autores principales: | Tomita, Taisuke, Wong, Philip C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226269/ https://www.ncbi.nlm.nih.gov/pubmed/21418547 http://dx.doi.org/10.1186/alzrt66 |
Ejemplares similares
-
Promotion in the Clearance of Aggregated Aβ In Vivo Using Amyloid Selective Photo-Oxygenation Technology
por: Hori, Yukiko, et al.
Publicado: (2022) -
Brain Ischemia Activates β- and γ-Secretase Cleavage of Amyloid Precursor Protein: Significance in Sporadic Alzheimer’s Disease
por: Pluta, Ryszard, et al.
Publicado: (2012) -
Galectin 3–binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein
por: Seki, Tsuneyoshi, et al.
Publicado: (2020) -
Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer’s disease
por: Serneels, Lutgarde, et al.
Publicado: (2020) -
Amyloid precursor protein: more than just neurodegeneration
por: Pimplikar, Sanjay W, et al.
Publicado: (2011)